The prognostic relevance of PAX7::FOXO1‐positive and FN alveolar rhabdomyosarcoma (aRMS), along with the clinical factors described in this report, allows further refinement of risk assessment of patients with localized and metastatic (aRMS). This evidence concerns the gene FOXO1 and rhabdomyosarcoma.